Search by Drug Name or NDC
NDC 42571-0274-60 ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE 25; 200 mg/1; mg/1 Details
ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE 25; 200 mg/1; mg/1
ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Micro Labs Limited. The primary component is ASPIRIN; DIPYRIDAMOLE.
MedlinePlus Drug Summary
The combination of aspirin and extended-release dipyridamole is in a class of drugs called antiplatelet agents. It works by preventing excessive blood clotting. It is used to reduce the risk of stroke in patients who have had or are at risk of stroke.
Related Packages: 42571-0274-60Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Aspirin and Extended-Release Dipyridamole
Product Information
| NDC | 42571-0274 |
|---|---|
| Product ID | 42571-274_ee82d0f1-56d0-10ec-e053-2995a90ac665 |
| Associated GPIs | 85159902206920 |
| GCN Sequence Number | 040303 |
| GCN Sequence Number Description | aspirin/dipyridamole CPMP 12HR 25MG-200MG ORAL |
| HIC3 | M9P |
| HIC3 Description | PLATELET AGGREGATION INHIBITORS |
| GCN | 95347 |
| HICL Sequence Number | 012474 |
| HICL Sequence Number Description | ASPIRIN/DIPYRIDAMOLE |
| Brand/Generic | Generic |
| Proprietary Name | ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ASPIRIN and Extended-Release DIPYRIDAMOLE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 25; 200 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | ASPIRIN; DIPYRIDAMOLE |
| Labeler Name | Micro Labs Limited |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregati |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA209929 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 42571-0274-60 (42571027460)
| NDC Package Code | 42571-274-60 |
|---|---|
| Billing NDC | 42571027460 |
| Package | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42571-274-60) |
| Marketing Start Date | 2021-08-16 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.65225 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | ASPIRIN-DIPYRIDAM ER 25-200 MG |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis